Postpartum Hemorrhage

Key Points

• Postpartum Hemorrhage occurs in about 1 to 5 percent of births and can progress rapidly to hypovolemic shock.
• ACOG defines postpartum hemorrhage as at least 1,000 mL blood loss or blood loss with hypovolemia signs within 24 hours after birth; more than 500 mL after vaginal birth still requires immediate clinical assessment.
• Early hemorrhage (birth to 24 hours) is most often due to uterine atony; late hemorrhage (after 24 hours to 12 weeks) is often linked to subinvolution or retained products.
• Hemorrhage during third stage or the first postpartum hour is treated as immediate postpartum hemorrhage, with tone-related causes most common.
• Quantitative blood loss (QBL) and rapid escalation are central to preventing preventable maternal mortality.
• Active-bleeding response should include early large-bore IV access, blood-bank preparation, and threshold-based transfusion escalation.
• In U.S. maternal-mortality reviews, hemorrhage remains a major contributor and many deaths are considered preventable with earlier recognition and escalation.

Pathophysiology

Postpartum hemostasis depends on strong uterine contraction and intact coagulation. When uterine tone is poor, tissue is retained, trauma is present, or clotting is impaired, blood loss can accelerate and exceed compensatory reserve. Because pregnancy increases blood volume by about 50 percent, clinical hypovolemia signs may appear late, so objective blood-loss measurement is essential.

Hemorrhage causes decreasing circulating volume, peripheral vasoconstriction, and shunting to vital organs. Without timely correction, maternal status can progress from weakness and dizziness to tachycardia, hypotension, hypoxia, oliguria, altered mental status, and loss of consciousness.

Classification

• Early (primary) PPH: Birth to 24 hours postpartum; commonly linked to the four Ts.
• Immediate PPH window: Third stage of labor through the first postpartum hour, requiring rapid cause-based intervention.
• Late (secondary) PPH: After 24 hours through 12 weeks postpartum; often associated with subinvolution, retained tissue, or coagulation abnormalities. At follow-up, subinvolution may present as a larger-than-expected uterus with lochia that has not progressed to alba.
• Etiologic framework (four Ts): Tone (atony; about 70 percent of PPH), Trauma (laceration, hematoma, inversion/rupture), Tissue (retained placenta), Thrombin (coagulation disorder, including obstetric DIC contexts).

Nursing Assessment

NCLEX Focus

Priority questions emphasize early recognition: increasing blood loss, boggy/deviated fundus, and evolving hypovolemia cues require immediate action.

• Perform QBL for all births and trend cumulative blood loss rather than relying on visual estimation.
• When feasible, perform QBL with standardized weighing/measuring of soaked pads, sponges, and disposable underpads.
• Recognize visual-estimate bias: small losses are often overestimated while large losses are commonly underestimated.
• Use structured PPH risk-assessment tools at admission/intrapartum handoff to identify high-risk patients and pre-stage hemorrhage resources.
• Prioritize objective blood-loss reassessment first when postpartum instability emerges, then continue cause-directed interventions.
• During the immediate postpartum hour, assess uterine location and tone frequently; a boggy or displaced uterus increases concern for atony-driven bleeding.
• During the first postpartum hour, pair frequent lochia reassessment with fundal checks: dark red lochia with small clots can be expected, while brisk bright red bleeding is concerning.
• If brisk bleeding persists with a firm uterus, increase suspicion for cervical, vaginal, or perineal laceration rather than isolated atony.
• In concealed-hemorrhage concern, treat heart rate 110 or greater, blood pressure 85/45 mm Hg or lower, O2 saturation below 95%, or new confusion as urgent hypovolemia cues.
• Watch for early hypovolemia cues (weakness, dizziness, anxiety, thirst, rising pulse/respiratory rate, and falling blood pressure) because pregnancy-related hypervolemia can mask severity.
• Treat pale/cool skin, diaphoresis, weak rapid pulse, dyspnea/air hunger, oliguria or anuria, restlessness, low body temperature, and new confusion/lethargy as shock-progression cues.
• Assess fundal tone, position, and bladder distention; a full bladder can worsen uterine atony.
• In atony risk contexts (prolonged or precipitous labor, prolonged oxytocin exposure, general anesthesia, uterine overdistention from macrosomia/multiple gestation/polyhydramnios, cesarean birth, chorioamnionitis, magnesium sulfate exposure), increase surveillance frequency.
• Consider urinary retention when bleeding persists with uterine deviation: signs include suprapubic fullness, frequent small-volume voids (often under 150 mL), and bladder discomfort.
• During early postpartum recovery, encourage voiding at least every 2 hours to reduce bladder-distention related atony risk.
• Monitor vital signs, oxygen saturation, mental status, skin perfusion, and urine output (target at least 30 mL/hr).
• Assess perineum/incision and symptoms of concealed bleeding such as hematoma pain and worsening instability.
• After cesarean birth, include abdominal/incision bleeding checks in serial hemorrhage reassessment.
• In trauma pathways, treat worsening focal perineal/pelvic pain with rising heart rate and falling blood pressure as potential expanding hematoma until proven otherwise.
• Track CBC and clotting studies in ongoing or severe hemorrhage pathways.

Nursing Interventions

• Initiate immediate fundal massage with uterine support and assist bladder emptying when atony is suspected.
• Activate hemorrhage response pathway and coordinate multidisciplinary support early.
• In third-stage/immediate-hour bleeding, prioritize rapid tone restoration because uterine atony is the dominant cause category.
• Establish one or two large-bore IV lines early and send type/screen with crossmatch preparation.
• Administer prescribed uterotonics and adjunct agents rapidly while reassessing response in real time.
• If heavy bleeding persists with a firm/contracted uterus, escalate rapidly for cervical or vaginal laceration evaluation and repair.
• If retained placental fragments or clots are suspected, prepare for provider-directed uterine evacuation.
• Support intravascular volume restoration with IV fluids and blood products as ordered; monitor for transfusion reactions and fluid overload.
• Use threshold-based transfusion planning: immediate transfusion is generally indicated at hemoglobin below 7 g/dL, or at 7 g/dL or higher when persistent tachycardia/hypotension does not respond to crystalloid bolus.
• Position with legs elevated, keep the patient warm, and titrate supplemental oxygen per protocol while definitive hemorrhage control is underway.
• Prepare escalation to mechanical tamponade or surgical management when bleeding persists despite first-line therapy.
• If hemorrhage continues after fundal massage and uterotonics, prepare for provider placement of intrauterine tamponade (for example, Bakri balloon) or vacuum-induced uterine-control systems (for example, Jada connected to wall/vacuum suction) before definitive surgery.
• If dedicated tamponade devices are unavailable, assist provider-directed uterine packing approaches per protocol while arranging definitive escalation.
• Prepare massive transfusion protocol when blood loss exceeds about 1500 mL or four or more units are required, and trend target labs (for example Hct about 25 to 30 percent, platelets 75,000/microL or higher, fibrinogen 300 mg/dL or higher, PT/aPTT under 1.5 times control).
• Teach immediate reporting thresholds in recovery: bleeding that soaks one or more pads in an hour or clots larger than an egg.
• After emergency peripartum hysterectomy, provide focused emotional support and grief-informed counseling about unexpected sterilization and recovery impact.
• In low-resource transfer settings, assist stabilization adjuncts such as non-pneumatic anti-shock garment (NASG) use per protocol while definitive hemorrhage care is being arranged.

Delayed Treatment Increases Mortality

Underestimation of blood loss and delayed escalation are major contributors to preventable maternal deaths from hemorrhage.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
uterotonics	Oxytocin, methylergonovine, misoprostol, carboprost	Oxytocin is first line; choose alternatives based on hypertension/asthma contraindications and side-effect profile.
antifibrinolytics	Tranexamic acid (TXA)	Give with uterotonic support in active hemorrhage; recommended early, ideally within 3 hours of birth.
intravenous-fluid-categories-tonicity-and-infusion-regulation (intravenous-fluids)	Isotonic crystalloid resuscitation context	Stabilizes perfusion while cause-targeted hemorrhage control proceeds.

• methylergonovine: avoid IV administration and avoid use with hypertension/preeclampsia due to hypertensive/cerebrovascular risk; temporary breastfeeding interruption with milk discard may be required per protocol.
• methylergonovine: for selected late-PPH/subinvolution pathways, oral short-course regimens may be used after acute stabilization per provider protocol.
• misoprostol: generally safe in asthma or hypertension; use caution with significant cardiovascular disease.
• carboprost: avoid in active cardiac, pulmonary, renal, or hepatic disease.
• TXA: avoid in active intravascular clotting; monitor for thromboembolic events, visual symptoms, or seizures.

Clinical Judgment Application

Clinical Scenario

Two hours postpartum, a patient has a boggy fundus deviated to the right, saturates a peripad, passes clots, and develops rising pulse with lightheadedness.

• Recognize Cues: Ongoing blood loss, uterine atony pattern, and early hypovolemia signs.
• Analyze Cues: Bladder distention and poor uterine contraction are likely driving hemorrhage.
• Prioritize Hypotheses: Immediate priority is restoring uterine tone and preventing progression to shock.
• Generate Solutions: Massage fundus, assist voiding/catheterization, quantify loss, give ordered uterotonics, and call hemorrhage team.
• Take Action: Implement hemorrhage protocol and prepare additional interventions if bleeding persists.
• Evaluate Outcomes: Fundus becomes firm/midline, blood loss slows, and perfusion parameters stabilize.

Related Concepts

• complications-in-the-third-stage-of-labor - Third-stage placental and tone problems are major antecedents of early PPH.
• monitoring-during-labor-for-emerging-complications - Ongoing surveillance supports rapid recognition of maternal deterioration.
• postpartum-infections - Retained tissue and invasive management may overlap infection and hemorrhage pathways.
• disseminated-intravascular-coagulation-in-pregnancy - Consumptive coagulopathy is a high-risk thrombin cause of severe or refractory bleeding.
• maternal-sepsis - Severe blood loss and invasive treatment can coexist with sepsis risk in complex postpartum cases.
• nursing-care-during-the-postpartum-period - Discharge teaching must include late-PPH warning signs and escalation instructions.

Self-Check

1. How does early postpartum hemorrhage differ from late postpartum hemorrhage in timing and common causes?
2. Why is quantitative blood loss superior to visual estimation during postpartum surveillance?
3. Which contraindications influence selection of methylergonovine or carboprost during PPH treatment?